Highlight
- A scalable, community-based antihypertensive intervention led by nonphysician providers significantly improved cardiovascular health metrics over 36 months.
- Blood pressure improvement was the primary driver of cardiovascular risk reduction, accounting for over two-thirds of the intervention’s benefit.
- Concurrent behavioral and metabolic improvements contributed modestly but meaningfully to risk reduction when combined with blood pressure control.
- Multidomain response heterogeneity provides a valuable framework for tailoring multifaceted cardiovascular intervention strategies.
Study Background
Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality, with hypertension as a key modifiable risk factor. The American Heart Association’s Life’s Simple 7 (LS7)—incorporating blood pressure, metabolic measures, and health behaviors—offers a multidimensional construct of cardiovascular health (CVH) to inform risk assessment and guide interventions. Although various studies have leveraged CVH metrics to develop targeted interventions, the complex, domain-specific patterns of CVH change following multifaceted antihypertensive interventions remain insufficiently understood. Understanding these patterns is critical to optimizing interventions for maximal cardiovascular benefit.
Study Design
This post hoc analysis of the China Rural Hypertension Control Project (CRHCP) evaluated 26,700 participants (mean age 62.5 years; 63.0% women) in a randomized community-based trial focused on intensive blood pressure management delivered by nonphysician community health care providers. The intervention targeted a blood pressure goal of under 130/80 mm Hg and engaged multiple LS7 domains: blood pressure, metabolic factors, and behavioral parameters (including lifestyle factors such as diet and physical activity).
Cardiovascular health metrics were longitudinally assessed over 0 to 36 months, and participants were grouped based on their domain-specific changes in blood pressure, metabolic, and behavioral components. Subsequent cardiovascular outcomes were tracked during months 36 to 48. The primary analytical approach used Cox proportional hazards models to evaluate associations between domain-specific change patterns and cardiovascular event risk.
Key Findings
The intervention improved overall LS7 scores by a net difference of 0.52 points (95% CI: 0.38–0.66) at 36 months, signifying meaningful cardiovascular health enhancement. Participants exhibiting improved CVH experienced a substantial cardiovascular risk reduction (hazard ratio [HR]: 0.71; 95% CI: 0.54–0.89).
Blood Pressure as the Predominant Beneficiary Domain
Longitudinal data revealed sustained and pronounced blood pressure improvements separating the intervention from control groups, whereas metabolic and behavioral components showed only modest and less distinct changes. Mediation analyses underscored that blood pressure improvements accounted for approximately 67.5% of the observed cardiovascular risk reduction.
Additional Contributions from Behavioral and Metabolic Domains
While metabolic improvements contributed minimally and behavioral changes modestly (8.0%) to risk reduction, participants who demonstrated combined gains in blood pressure plus either behavioral or metabolic domains experienced the greatest cardiovascular risk reduction (HR: 0.57; 95% CI: 0.30–0.84). Blood pressure improvement alone conferred a significant, albeit smaller, benefit (HR: 0.76; 95% CI: 0.55–0.98). No significant cardiovascular risk benefit was associated with gains in behavioral or metabolic domains without concomitant blood pressure improvement.
Safety and Consistency
The intervention was implemented safely in a rural, resource-limited setting, utilizing nonphysician providers, highlighting scalability. Sensitivity analyses confirmed the robustness of the findings.
Expert Commentary
This CRHCP post hoc analysis enriches current understanding by quantitatively delineating how domain-specific cardiovascular health changes translate into clinical outcomes. The predominant role of blood pressure control aligns with established hypertension management guidelines emphasizing rigorous blood pressure targets to reduce CVD risk.
The modest additive impact of behavioral and metabolic improvements suggests that while these domains are important for holistic cardiovascular health, their influence on short-term clinical event reduction is more subtle. This may reflect challenges in achieving sustainable behavioral modification or metabolic control within the studied time frame.
Importantly, the heterogeneity of responses supports personalized intervention approaches. Health systems may prioritize blood pressure optimization while concurrently promoting lifestyle and metabolic improvements to amplify cardiovascular benefits, especially in underserved rural populations.
However, limitations include the post hoc nature of the analysis and reliance on LS7 components which may not capture all relevant risk factors. The generalizability outside rural China warrants further investigation.
Conclusion
The CRHCP trial demonstrates that community-based, multifaceted interventions led by nonphysician providers can effectively improve cardiovascular health and reduce risk primarily through blood pressure control. Incorporating behavioral and metabolic improvements yields additional, though smaller, benefits, illustrating the value of multidimensional strategies. The findings provide a quantitative framework to understand the translation of complex interventions into clinical outcomes and underscore the critical importance of blood pressure management in cardiovascular risk reduction.
Funding and Registration
The China Rural Hypertension Control Project was registered at ClinicalTrials.gov (NCT03527719). Funding sources and detailed trial protocols can be accessed through the registry and original publication.
References
Guo X, Sun G, Xie Z, Zhou S, Ye N, et al. Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial. J Am Coll Cardiol. 2026 Jun 26; [Epub ahead of print]. PMID: 42417693.
American Heart Association. Life’s Simple 7 Metrics and Cardiovascular Health. Circulation. 2010;121(15):586-95.
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13-e115.
